U.S. Healthcare Third-party Logistics Market Size, Share & Trends Analysis Report By Industry (Biopharmaceutical, Pharmaceutical, Medical Device), By Supply Chain, By Service Type, By Region, And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. healthcare third-party logistics market size was exhibited at USD 81.19 billion in 2022 and is projected to hit around USD 193.09 billion by 2032, growing at a CAGR of 9.05% during the forecast period 2023 to 2032.

U.S. Healthcare Third-party Logistics Market Size, 2023 to 2032

Key Takeaways:

  • The biopharmaceutical segment dominated the overall market with a revenue share of over 61.0% in 2022.
  • The medical device segment is expected to witness the fastest growth over the forecast period.
  • The non-cold chain logistics segment generated the largest revenue share of over 60.9% in 2022.
  • Cold chain logistics is expected to showcase a significant market share in the coming years.
  • The warehousing and storage segment dominated with the largest revenue share of over 41.0% in 2022.In the healthcare industry
  • The other services segment is expected to register the fastest CAGR during the forecast period.
  • The Midwest region dominated the overall market share of over 26.9% in 2022.
  • The Northeast region is expected to show significant growth in the forecast period.

U.S. Healthcare Third-party Logistics Market Report Scope

Report Attribute Details
Market Size in 2023 USD 88.54 Billion
Market Size by 2032 USD 193.09 Billion
Growth Rate From 2023 to 2032 CAGR of  9.05%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Industry, Supply chain, Service type, Region 
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled ShipMonk; DHL International; Cardinal Health; MCKESSON CORPORATION; Kuehne+Nagel; AmerisourceBergen Corporation; C.H. Robinson; CEVA Logistics; Promptus, LLC; FedEx

 

The market has been growing significantly due to the expanding e-commerce sector. Healthcare companies are using online platforms to sell their products because they lack the resources to provide their own logistics services, which has increased the demand for third-party logistics. Increasing technological advancements in the domain is expected to create growth opportunity for the market. The adoption of advanced technologies such as real-time tracking systems, the Internet of Things (IoT), and blockchain is becoming more accepted in healthcare logistics. These technologies support shipment tracking, visibility enhancement, and product integrity, which improve supply chain management and increase customer experience.

A complex regulatory environment related to pharmaceutical and medical devices is further expected to provide this market with growth opportunities. Storage, handling, and transportation of drugs and medical devices are all subject to stringent regulations and compliance standards in the healthcare industry. The third-party logistics entities offer expertise in navigating regulatory frameworks that can aid healthcare companies ensure compliance and avoid penalties. Safety measures and quality control requirements are often part of regulatory compliance. Third-party logistic entities help their clients maintain and implement these standards throughout the supply chain.

The COVID-19 pandemic significantly impacted the market. The COVID-19 pandemic resulted in increased demand for medical supplies such as ventilators, personal protective equipment, and other crucial products. As a result, several companies in the market adopted the changing needs of the healthcare business to meet the demand. Moreover, the COVID-19 pandemic contributed to increased partnerships between healthcare entities with third-party logistics companies to operate in a growing and changing demand.

Industry Insights

The biopharmaceutical segment dominated the overall market with a revenue share of over 61.0% in 2022. This dominance is attributed to an increase in the number of biosimilar introductions and pharmaceutical companies' focus on their distribution network.Technological advances have increased the use of temperature management logistic services. Furthermore, the growing trend of medical companies outsourcing logistics to strengthen their distribution system is also expected to boost the segment’s growth.

The medical device segment is expected to witness the fastest growth over the forecast period. Supply chains in the medical device sector are complex and involve the sourcing of raw materials, manufacturing procedures, quality control, and distribution. 3PL providers offer expertise in enhancing productivity, cutting costs, and streamlining supply chains. They can help with order fulfillment, inventory management, shipping, and warehousing, guaranteeing a smooth supply chain from the point of production to the end-user.

Supply Chain Insights

The non-cold chain logistics segment generated the largest revenue share of over 60.9% in 2022.This is due to the rising sales of pharmaceuticals through distributors. Scalability, reduced operational costs, higher profits, and fewer risks are all features of logistic services. Due to all these advantages, third-party logistic providers have become an essential component of the pharmaceutical business.

Cold chain logistics is expected to showcase a significant market share in the coming years. There is increasing demand for temperature-sensitive biologics, pharmaceuticals, vaccines, and other healthcare products in the U.S. This demand is driven by factors such as the introduction of advanced therapies, an aging population, and the need for effective disease control. These pharmaceutical products need strict temperature control throughout the supply chain, resulting in raised dependence on cold chain logistics.

Service Type Insights

The warehousing and storage segment dominated with the largest revenue share of over 41.0% in 2022.In the healthcare industry, efficient inventory management is essential to ensuring the availability and prompt delivery of drugs and medical supplies. Warehousing and storage entities offer services such as stock rotation, and inventory tracking to simplify the supply chain processes. These services assist healthcare facilities in minimizing stockouts, increasing operational effectiveness, and optimizing inventory levels. Such advantages are expected to boost the segment growth. 

The other services segment is expected to register the fastest CAGR during the forecast period.This segment includes custom & duty management, packaging, procurement services, and a few other value-added services.Procurement services are one of the crucial services of healthcare logistics. To ensure that production costs do not exceed a company's budget objectives, procurement and logistics management must coexist and function together efficiently. 

Regional Insights

The Midwest region dominated the overall market share of over 26.9% in 2022. Pharmaceutical and biotechnology companies are largely concentrated in the Midwest. These companies produce a wide variety of healthcare products, such as pharmaceuticals, biologics, medical equipment, and diagnostics. Third-party logistics services, such as warehousing, shipping, and distribution, are in high demand in the area as a result of the presence of these firms, which contributes to the Midwest's dominant position in the market.

The Northeast region is expected to show significant growth in the forecast period. The Northeast region is expected to show significant growth in the forecast period. The Northeast region has a well-established healthcare infrastructure, including clinics, hospitals, healthcare networks, and research institutions. Healthcare providers in the area rely on effective supply chain and logistics solutions for the efficient availability of equipment, drugs, and medical supplies.

Key Companies & Market Share Insights

The key entities in the market entered into various strategic initiatives, such as new service launches, partnerships, and mergers & acquisitions, to expand their position in the market. For instance,in February 2022, DHL Supply Chain invested around USD 400 million to expand its network for distributing pharmaceutical and medical devices in the U.S. DHL Supply Chain's latest investment includes six additional U.S. sites by the end of 2022 with the ultimate goal of bringing essential healthcare supplies closer to business partners and patients. Some prominent players in the U.S. healthcare third-party logistics market include:

  • ShipMonk
  • DHL International
  • Cardinal Health
  • MCKESSON CORPORATION
  • Kuehne+Nagel
  • AmerisourceBergen Corporation
  • C.H. Robinson
  • CEVA Logistics
  • Promptus, LLC
  • FedEx

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Healthcare Third-party Logistics market.

By Industry 

  • Biopharmaceutical
  • Pharmaceutical
  • Medical Device

By Supply Chain 

  • Cold Chain
  • Non-cold Chain

By Service Type 

  • Transportation
    • Air Freight
    • Sea Freight
    • Overland Transportation
  • Warehousing And Storage
  • Others

By Regional 

  • Northeast
  • Southwest
  • West
  • Southeast
  • Midwest

Frequently Asked Questions

The U.S. healthcare third-party logistics market size was exhibited at USD 81.19 billion in 2022 and is projected to hit around USD 193.09 billion by 2032

The U.S. Healthcare Third-party Logistics market is growing at a compound annual growth rate (CAGR) of 9.05% from 2023 to 2032.

Some prominent players in the U.S. healthcare third-party logistics market include: ShipMonk; DHL International; Cardinal Health; MCKESSON CORPORATION; Kuehne+Nagel; AmerisourceBergen Corporation; C.H. Robinson; CEVA Logistics; Promptus, LLC; FedEx

Chapter 1. Methodology and Scope
                    1.1. Information Procurement
                    1.2. Information or Data Analysis
                    1.3. Market Scope & Segment Definition
                    1.4. Market Model
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Trends and Outlook
                    3.4. Market Driver Analysis
                    3.5. Market Restraint Analysis
                    3.6. Business Environment Analysis
                        3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
                        3.6.2. Porter’s Five Forces Analysis
                    3.7. COVID-19 Impact Analysis
Chapter 4. Industry Analysis
                    4.1. U.S. Healthcare Third-Party Logistics Market: Industry Movement Analysis
                    4.2. Biopharmaceutical
                        4.2.1. Biopharmaceutical Market, 2020 - 2032
                    4.3. Pharmaceutical
                        4.3.1. Pharmaceutical Market, 2020 - 2032
                    4.4. Medical Device
                        4.4.1. Medical Device Market, 2020 - 2032
Chapter 5. Supply Chain Business Analysis
                    5.1. U.S. Healthcare Third-Party Logistics Market: Supply Chain Movement Analysis
                    5.2. Cold chain
                        5.2.1. Cold chain Market, 2020 - 2032
                    5.3. Non-Cold chain
                        5.3.1. Non-Cold Chain Market, 2020 - 2032
Chapter 6. Service Type Business Analysis
                    6.1. U.S. Healthcare Third-Party Logistics Market: Service Type Movement Analysis
                    6.2. Transportation
                        6.2.1. Transportation Market, 2020 - 2032
                            6.2.1.1. Air Freight
                                6.2.1.1.1. Air freight Market, 2020 - 2032
                            6.2.1.2. Sea freight
                                6.2.1.2.1. Sea freight Market, 2020 - 2032
                            6.2.1.3. Overland transportation
                                6.2.1.3.1. Overland transportation Market, 2020 - 2032
                    6.3. Warehousing and storage
                        6.3.1. Warehousing and storage Market, 2020 - 2032
                    6.4. Others
                        6.4.1. Others Logistic Market, 2020 - 2032
Chapter 7. Region Analysis
                    7.1. U.S. Healthcare Third-Party Logistics Market: Region Movement Analysis
                    7.2. Northeast
                        7.2.1. Northeast Healthcare Logistic Market, 2020 - 2032
                    7.3. Southwest
                        7.3.1. Southwest Healthcare Logistic Market, 2020 - 2032
                    7.4. West
                        7.4.1. West Healthcare Logistic Market, 2020 - 2032
                    7.5. Southeast
                        7.5.1. Southeast Healthcare Logistic Market, 2020 - 2032
                    7.6. Midwest
                        7.6.1. Midwest Healthcare Logistic Market, 2020 - 2032
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Company Market Position Analysis, 2023
                    8.3. Strategy Mapping
                        8.3.1. Expansion
                        8.3.2. Acquisition
                        8.3.3. Collaborations
                        8.3.4. New Product Launches
                        8.3.5. Partnerships
                        8.3.6. Others
                    8.4. Participant’s overview
                        8.4.1. ShipMonk
                            8.4.1.1. Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Strategic Initiatives
                        8.4.2. DHL International
                            8.4.2.1. Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Strategic Initiatives
                        8.4.3. Cardinal Health
                            8.4.3.1. Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Strategic Initiatives
                        8.4.4. MCKESSON CORPORATION
                            8.4.4.1. Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Strategic Initiatives
                        8.4.5. Kuehne+Nagel
                            8.4.5.1. Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Strategic Initiatives
                        8.4.6. AmerisourceBergen Corporation
                            8.4.6.1. Overview
                            8.4.6.2. Financial Performance
                            8.4.6.3. Product Benchmarking
                            8.4.6.4. Strategic Initiatives
                        8.4.7. C.H. Robinson
                            8.4.7.1. Overview
                            8.4.7.2. Financial Performance
                            8.4.7.3. Product Benchmarking
                            8.4.7.4. Strategic Initiatives
                        8.4.8. CEVA Logistics
                            8.4.8.1. Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Strategic Initiatives
                        8.4.9. Promptus, LLC
                            8.4.9.1. Overview
                            8.4.9.2. Financial Performance
                            8.4.9.3. Product Benchmarking
                            8.4.9.4. Strategic Initiatives
                        8.4.10. FedEx
                            8.4.10.1. Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Strategic Initiatives

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers